Skip to main content
Ascletis Pharma Inc. logo

Ascletis Pharma Inc. — Investor Relations & Filings

Ticker · 1672 ISIN · KYG0520K1094 LEI · 254900SKEFCO9I3GPL05 HKEX Manufacturing
Open in API
Filings indexed 1,471 across all filing types
Latest filing 2021-10-11 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 1672

About Ascletis Pharma Inc.

http://www.ascletis.com

Ascletis Pharma Inc. is a fully integrated, R&D driven biotechnology company dedicated to the development and commercialization of potential best-in-class and first-in-class therapeutics. The company covers the entire value chain from discovery to sales. Ascletis primarily focuses on metabolic diseases, including chronic weight management, utilizing proprietary platforms such as Artificial Intelligence-assisted Structure-Based Drug Discovery (AISBDD), Ultra-Long-Acting Platform (ULAP), and Peptide Oral Transport ENhancement Technology (POTENT). Key pipeline candidates include ASC30 (oral/subcutaneous GLP-1R agonist), ASC35 (GLP-1R/GIPR dual agonist), ASC36 (amylin receptor agonist), and ASC37 (GLP-1R/GIPR/GCGR triple agonist). The company also maintains active programs in viral diseases, NASH/PBC, and oncology.

Recent filings

Filing Released Lang Actions
VOLUNTARY ANNOUNCEMENT UNUSUAL PRICE AND VOLUME MOVEMENTS
Regulatory Filings Classification · 95% confidence The document is a short announcement from the Board of World Houseware (Holdings) Limited regarding unusual price and volume movements of the company's shares. It explicitly states it is a "Voluntary Announcement" and does not contain any financial statements, detailed financial data, or report content. The document is under 5,000 characters and serves to inform the market about share price activity and the company's current status on related matters. It does not present an annual report, interim report, earnings release, or any detailed financial or management information. It is not a certification or legal proceeding update. The nature of the announcement fits best with a Regulatory Filing (RNS) as a general regulatory announcement that does not fit other specific categories.
2021-10-11 English
VOLUNTARY ANNOUNCEMENT UNUSUAL PRICE AND VOLUME MOVEMENTS
Regulatory Filings Classification · 95% confidence The document is a short announcement from the Board of World Houseware (Holdings) Limited regarding unusual price and volume movements of the company's shares. It explicitly states it is a "Voluntary Announcement" and does not contain any financial statements, detailed financial data, or report content. The document is under 5,000 characters and serves to inform the market about share price activity and the company's current status on related matters. It does not present an annual report, interim report, earnings release, or any detailed financial or management information. It is not a certification or legal proceeding update. The nature of the announcement fits best with a Regulatory Filing (RNS) as a general regulatory announcement that does not fit other specific categories.
2021-10-08 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Ascletis Pharma Inc. It references specific listing rules from the Stock Exchange of Hong Kong (SEHK) and details repurchases of shares, including dates, quantities, and prices. The content is focused on disclosure of share repurchases and changes in issued shares, with confirmations from company officers about compliance with listing rules. There are no financial statements or comprehensive financial performance data, so it is not an Annual Report or Interim Report. It is not a general regulatory filing or announcement of a report but a specific disclosure about share capital changes and repurchases. This fits the definition of a Transaction in Own Shares (POS) filing, which reports the company's buyback or sale of its own shares.
2021-10-08 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Ascletis Pharma Inc. It includes detailed information about repurchase of shares, dates, prices, and confirmations related to compliance with listing rules on the Stock Exchange of Hong Kong. The content focuses on reporting share repurchases and changes in issued shares, which aligns with announcements regarding share buybacks or capital changes. There is no indication that this is a full financial report, earnings release, or management discussion. The document is not a report publication announcement but a regulatory disclosure of share capital changes. Therefore, the most appropriate classification is 'Transaction in Own Shares' (POS).
2021-10-07 English
VOLUNTARY ANNOUNCEMENT - PROPOSED SHARE REPURCHASE UNDER THE REPURCHASE MANDATE
Transaction in Own Shares Classification · 95% confidence The document is a voluntary announcement by Ascletis Pharma Inc. regarding a proposed share repurchase under an existing repurchase mandate approved at the AGM. It discusses the intention to repurchase shares on the open market, the financial position of the company, and compliance with listing rules. The document is an announcement of a share buyback plan, not the actual transaction or detailed financial report. It is relatively short (4160 characters) and serves as a notification to shareholders and the market about the company's intention to repurchase shares. Therefore, it fits the category of a Transaction in Own Shares (POS) announcement rather than a full financial report or other categories.
2021-10-06 English
Next Day Disclosure Return
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and/or share buybacks for World Houseware (Holdings) Limited. It details the exercise of share options by directors, changes in issued shares, and confirmations related to share issuance compliance with listing rules. The content focuses on share capital changes and disclosures pursuant to stock exchange rules, specifically referencing the Stock Exchange of Hong Kong Limited. This matches the description of announcements regarding share issues or capital changes. The document is not a full financial report, earnings release, or management discussion, but a regulatory disclosure about share capital changes. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length and detail support a high confidence classification.
2021-10-04 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.